Evidence map›Paper›PMID 31303360›Full record

ArticleJournal of substance abuse treatment2020

Assessing the needs of front-line providers in addressing the opioid crisis in South Carolina.

Angela Moreland, Jenna McCauley, Kelly Barth, Carolyn Bogdon, Therese Killeen, Louise Haynes, Lindsey Jennings, Constance Guille, Sara Goldsby, Kathleen Brady

Abstract read
In one paragraph

Article in Journal of substance abuse treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Angela MorelandMedical University of South Carolina, United States of America. Electronic address: moreland@musc.edu.
Jenna McCauleyMedical University of South Carolina, United States of America.
Kelly BarthMedical University of South Carolina, United States of America.
Carolyn BogdonMedical University of South Carolina, United States of America.
Therese KilleenMedical University of South Carolina, United States of America.
Louise HaynesMedical University of South Carolina, United States of America.
Lindsey JenningsMedical University of South Carolina, United States of America.
Constance GuilleMedical University of South Carolina, United States of America.
Sara GoldsbySouth Carolina Department of Alcohol and Other Drug Abuse Services, United States of America.
Kathleen BradyMedical University of South Carolina, United States of America.

Funding

Clinical Scientists Training Program in Addictions at MUSCK12DA031794 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Kevin M. Gray, AIMEE L MCRAE-CLARK · 2013 to 2026
$7.2M
Interdisciplinary Women's Health Research at MUSCK12HD055885 · NICHD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCGINTY, JACQUELINE F. · 2007 to 2021
$7.2M
Drug Abuse Research Training (DART) ProgramR25DA020537 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KATHLEEN T. BRADY, Sudie E Back · 2006 to 2026
$6.3M
Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine TaperK23DA039328 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BARTH, KELLY S. · 2016 to 2019
$787k
NICHD NIH HHS K12 HD055885NIDA NIH HHS K12 DA031794NIDA NIH HHS K23 DA039328NIDA NIH HHS R25 DA020537
6 · The paper itself

Abstract

Opioid use disorder (OUD) has been declared a national crisis, as prevalence of OUD has increased remarkably over the past decade (Jones, 2017). While Medication Assisted Treatment (MAT) is the standard of care for OUDs, several key barriers to implementation have been noted throughout the clinical and research literature (DeFlavio et al., 2015). As a first step toward enhancing implementation and dissemination of MAT across the state of South Carolina, a needs assessment was conducted with key persons from 33 agencies to inform our efforts. Results provided descriptive information regarding medical providers and patients seen within agencies. Of the 33 agencies, 6 agencies (18%) reported having buprenorphine-waivered providers on staff (total of 11 medical providers across the 6 agencies). Agencies reported that they referred a mean of 4.63 patients to other facilities for MAT in the past month. Barriers to providing MAT were identified, with the most significant barrier including the lack of medical staff to prescribe buprenorphine (47%). Overall, the current study reiterates the gap between treatment need and capacity for OUD patients, and highlights factors associated with barriers to MAT adoption in state-funded county drug and alcohol agencies across a southern, predominantly rural state.

Indexed as

Needs AssessmentOpioid EpidemicPractice Patterns, Physicians'BuprenorphineHealth PersonnelHealth Services AccessibilityHumansOpiate Substitution TreatmentOpioid-Related DisordersReferral and ConsultationRural PopulationSouth CarolinaBuprenorphine

Identifiers

PMID31303360
PMCPMC6893121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.